For instance, in the TME in prostate cancer, if PER expression is too low, BMAL1 expression increases, thus resulting in up-regulation of β-Catenin phosphorylation and activation of the Wnt/β-Catenin pathway. This evidence concerns the gene PER1 and prostate cancer.